Abata Therapeutics logo

Abata Therapeutics Funding & Investors

Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases.

abatatx.com

Total Amount Raised: $95,000,000

Abata Therapeutics Funding Rounds

  • Series A

    $95,000,000

    Series A Investors

    Third Rock Ventures
    ElevateBio
    Invus
    Lightspeed Venture Partners
    JDRF T1D Fund
    Samsara BioCapital
Funding info provided by Diffbot.